235 related articles for article (PubMed ID: 17552003)
1. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
[TBL] [Abstract][Full Text] [Related]
2. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.
Ferrasi AC; Pinheiro NA; Rabenhorst SH; Caballero OL; Rodrigues MA; de Carvalho F; Leite CV; Ferreira MV; Barros MA; Pardini MI
World J Gastroenterol; 2010 Jan; 16(3):312-9. PubMed ID: 20082476
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
Schildhaus HU; Kröckel I; Lippert H; Malfertheiner P; Roessner A; Schneider-Stock R
Int J Oncol; 2005 Jun; 26(6):1493-500. PubMed ID: 15870861
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
Oue N; Sentani K; Yokozaki H; Kitadai Y; Ito R; Yasui W
Pathobiology; 2001; 69(3):143-9. PubMed ID: 11872960
[TBL] [Abstract][Full Text] [Related]
7. [Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):978-81. PubMed ID: 17650424
[TBL] [Abstract][Full Text] [Related]
8. Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study.
Li Z; Ding Y; Zhu Y; Yin M; Le X; Wang L; Yang Y; Zhang Q
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):744-50. PubMed ID: 25091631
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation Status of E-Cadherin Gene in Gastric Cancer Patients in a High Incidence Area.
Rashid H; Alam K; Afroze D; Yousuf A; Banday M; Kawoosa F
Asian Pac J Cancer Prev; 2016; 17(6):2757-60. PubMed ID: 27356686
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of RAR-β tumor suppressor gene in gastric carcinoma: Association with histological type and clinical outcomes.
Mohsenzadeh M; Sadeghi RN; Vahedi M; Kamani F; Hashemi M; Asadzadeh H; Zali MR
Cancer Biomark; 2017 Jul; 20(1):7-15. PubMed ID: 28759951
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair gene methylation in gastric cancer in individuals from northern Brazil.
Moura Lima E; Ferreira Leal M; Cardoso Smith Mde A; Rodríguez Burbano R; Pimentel de Assumpção P; Bello MJ; Rey JA; Ferreira de Lima F; Casartelli C
Biocell; 2008 Dec; 32(3):237-43. PubMed ID: 19181186
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
14. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil.
Borges Bdo N; Santos Eda S; Bastos CE; Pinto LC; Anselmo NP; Quaresma JA; Calcagno DQ; Burbano RM; Harada ML
Anticancer Res; 2010 Jun; 30(6):2225-33. PubMed ID: 20651373
[TBL] [Abstract][Full Text] [Related]
15. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.
Graziano F; Arduini F; Ruzzo A; Bearzi I; Humar B; More H; Silva R; Muretto P; Guilford P; Testa E; Mari D; Magnani M; Cascinu S
Clin Cancer Res; 2004 Apr; 10(8):2784-9. PubMed ID: 15102685
[TBL] [Abstract][Full Text] [Related]
16. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype.
Endoh Y; Tamura G; Ajioka Y; Watanabe H; Motoyama T
Am J Pathol; 2000 Sep; 157(3):717-22. PubMed ID: 10980110
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
19. [Promoter methylation profile in gastric cancer].
Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
[TBL] [Abstract][Full Text] [Related]
20. Comparison of CDH1 Gene Hypermethylation Status in Blood and Serum among Gastric Cancer Patients.
Li Z; Guo Z
Pathol Oncol Res; 2020 Apr; 26(2):1057-1062. PubMed ID: 30989488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]